Skip to main content

Keryx Biopharmaceuticals (NASDAQ: KERX) Investor Securities Class Action Lawsuit 08/02/2016

  • If you purchased shares of Keryx Biopharmaceuticals (NASDAQ: KERX), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

April1, 2019 - The case was voluntarily dismissed. July 19, 2018 - The court granted in part and denied in part the defendants' motion to dismiss. October 2, 2017 - A motion to dismiss the amended complaint was filed. April 6, 2017 - The case was transferred to the U.S. District Court for the District of Massachusetts. February 27, 2017 - An amended complaint was filed. August 2, 2016...



You must register (for free) or login to view the entire case.